Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether LJP 394 (abetimus sodium) is safe and
effective in delaying and reducing renal flares in patients with lupus nephritis.